On Demand Audio

Recent Supreme Court and Federal Circuit Patent Case Law Roundup

(488 reviews)

Produced on October 22, 2018

Taught by
$ 89 Intellectual Property and Patent In Stock
Get started now

$299 / year - Access to this Course and 1,500+ Lawline courses


Course Information

Time 1h 4m
Difficulty Intermediate
Topics covered in this course: Intellectual Property Patent

Course Description

Patent law is changing rapidly and the pace of that change has only accelerated over the past few years, with important new decisions issuing from the Supreme Court and the Federal Circuit on a monthly basis. This course, led by attorney Christopher Loh, aims to catch up in-house patent practitioners and outside counsel on the latest developments in patent case law in 2018.

This includes a review of the Oil States, SAS, and WesternGeco Supreme Court decisions from last term, a preview of the Helsinn on-sale Supreme Court case on deck for next term, and several other important Federal Circuit decisions (Berkheimer, Allergan v. St. Regis, Vanda) that affect both substantive patent law and procedural issues of interest to IP stakeholders.

Learning Objectives:

  1. Address important Supreme Court patent law decisions
  2. Break down recent Federal Circuit Court decisions
  3. Dig into the upcoming issues of Helsinn
  4. Identify substantive legal impacts and procedural issues for IP stakeholders

Credit Information

After completing this course, Lawline will report your attendance information to {{ accredMasterState.state.name }}. Please ensure your license number is filled out in your profile to ensure timely reporting. For more information, see our {{ accredMasterState.state.name }} CLE Requirements page . After completing this course, {{ accredMasterState.state.name }} attorneys self-report their attendance and CLE compliance. For more information on how to report your CLE courses, see our {{ accredMasterState.state.name }} CLE Requirements FAQ .


Christopher E. Loh

Venable LLP

Christopher Loh practices complex patent litigation in the areas of pharmaceuticals, biotechnology and chemistry. Over the past fifteen years, he has litigated patent cases involving anti-HIV therapies, anti-hepatitis drugs, antidepressants and statins, including as lead counsel. He has experience arguing before the United States Court of Appeals for the Federal Circuit, and has won on behalf of patent owners in inter partes review proceedings before the Patent Trial and Appeal Board. In addition to his litigation work, Christopher also counsels clients on transactional and patent prosecution issues concerning both small-molecule drugs and biological products such as recombinant antibodies, and advises clients on a range of intellectual property matters including inventorship, trade secrets, and licensing.

Christopher is a frequent author and commentator on intellectual property issues, and has twice won the Burton Award for Legal Achievement in recognition of his exceptional writing. His publications have appeared in Lexology, the National Law Journal, the New York Law Journal, Bloomberg IP and Managing Intellectual Property.

In law school, Christopher served as Notes Editor for the Columbia Business Law Review and also interned at the New York Volunteer Lawyers for the Arts, counseling clients on copyright, trademark and artist rights issues.


Kevin G.

good course

Harrison O.

Fascinating material

Steven T.

Nice job!

Donna A.

good update

John R.

Very well done. Great speaker.

Richard D.


Geoffrey D.

Excellent timely presentatinon.

Yekaterina A.

Good level for lawyers specialized in this field. Please provide more courses of this type.

Nicolas G.

Very good presentation of patent holdings in 2018.

John S.

An excellent program!

Earl B.

quite complete and up-to-the minute survey

Christopher R. C.

Excellent program content.

Sue L.

The speaker was very professional and his presentation was very informative.

Load More